This Article Full Text Full Text (PDF) All Versions of this Article: 44/5/746    most recent 01.HYP.0000144801.09557.4cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Franco, V. Articles by Perry, G. Search for Related Content PubMed PubMed Citation Articles by Franco, V. Articles by Perry, G. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections Structure Contractile function Other heart failure Remodeling Other hypertension Heart failure - basic studies Physiological and pathological control of gene expression

(Hypertension. 2004;44:746.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Atrial Natriuretic Peptide Dose-Dependently Inhibits Pressure Overload-Induced Cardiac Remodeling

Veronica Franco; Yiu-Fai Chen; Suzanne Oparil; Ji An Feng; Dajun Wang; Fadi Hage; Gilbert Perry

From the Vascular Biology and Hypertension Program (V.F., Y.-F.C., S.O., J.A.F., D.W., F.H., G.P.), Division of Cardiovascular Disease, University of Alabama at Birmingham, and the Cardiology Section (G.P.), Birmingham VA Medical Center, Birmingham, Ala.

Correspondence to Veronica Franco, MD, University of Alabama at Birmingham, ZRB 1024, 703 19th St S, Birmingham, AL 35294. E-mail vfranco{at}uab.edu

We hypothesized that a single copy of the proatrial natriuretic peptide gene (Nppa^+/–) would not be adequate to protect heterozygous mice against exaggerated cardiac hypertrophy and remodeling after pressure-overload stress. Nppa^+/+, Nppa^+/–, and Nppa^–/– mice were subjected to sham surgery or transverse aortic constriction and fed a basal salt diet. Heart weight varied inversely with Nppa gene load by 1 week after either surgery. Fractional shortening did not differ among genotypes at baseline and fell in Nppa^–/– mice only after transverse aortic constriction. There was a graded response in collagen deposition related to atrial natriuretic peptide (ANP) expression after either surgery. A robust interstitial and perivascular fibrosis was noted in Nppa^–/– and Nppa^+/– but not in Nppa^+/+ mice after transverse aortic constriction. Our findings are consistent with a growing body of evidence that ANP is an important modulator of cardiac hypertrophy and remodeling in response to hemodynamic stress. The observation that partial ANP deficiency results in exaggerated hypertrophy and remodeling after pressure overload suggests that genetic or environmental variation in ANP levels may play a role in the development of cardiac hypertrophy, remodeling, and failure in humans.

Key Words: atrial natriuretic factor • natriuretic peptides • receptors, atrial natriuretic factor • hypertrophy, cardiac • remodeling • extracellular matrix • collagen

This article has been cited by other articles:

				S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494. [Abstract] [Full Text] [PDF]

				I. L.O. Buxton and D. Duan Cyclic GMP/Protein Kinase G Phosphorylation of Smad3 Blocks Transforming Growth Factor-{beta}-Induced Nuclear Smad Translocation: A Key Antifibrogenic Mechanism of Atrial Natriuretic Peptide Circ. Res., February 1, 2008; 102(2): 151 - 153. [Full Text] [PDF]

				P. Li, D. Wang, J. Lucas, S. Oparil, D. Xing, X. Cao, L. Novak, M. B. Renfrow, and Y.-F. Chen Atrial Natriuretic Peptide Inhibits Transforming Growth Factor {beta}-Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts Circ. Res., February 1, 2008; 102(2): 185 - 192. [Abstract] [Full Text] [PDF]

				G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11. [Abstract] [Full Text] [PDF]

				D. B. Murray, J. D. Gardner, S. P. Levick, G. L. Brower, L. G. Morgan, and J. S. Janicki Response of cardiac mast cells to atrial natriuretic peptide Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1216 - H1222. [Abstract] [Full Text] [PDF]

				S J. Sangaralingham, M Y. Tse, and S. C Pang Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice J. Endocrinol., July 1, 2007; 194(1): 143 - 152. [Abstract] [Full Text] [PDF]

				A. M. Richards Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use Hypertension, July 1, 2007; 50(1): 25 - 30. [Full Text] [PDF]

				V. Franco and S. Oparil Is There a New Treatment for Hypertensive Disease in the Horizon?: Role of Soluble Guanylate Cyclase Hypertension, November 1, 2006; 48(5): 822 - 823. [Full Text] [PDF]

				A. Maguy, T. E. Hebert, and S. Nattel Involvement of lipid rafts and caveolae in cardiac ion channel function Cardiovasc Res, March 1, 2006; 69(4): 798 - 807. [Abstract] [Full Text] [PDF]

				T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardioprotection Cardiovasc Res, February 1, 2006; 69(2): 318 - 328. [Abstract] [Full Text] [PDF]

				G. W. Booz Putting the Brakes on Cardiac Hypertrophy: Exploiting the NO-cGMP Counter-Regulatory System Hypertension, March 1, 2005; 45(3): 341 - 346. [Abstract] [Full Text] [PDF]